TRANSFORMED LYMPHOMA

Clinical trials for TRANSFORMED LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new TRANSFORMED LYMPHOMA trials appear

Sign up with your email to follow new studies for TRANSFORMED LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 2

Immune-Guiding antibody aims to clean up remaining cancer cells after transplant

Disease control Ongoing

This early-phase study tests whether adding mosunetuzumab after a stem cell transplant is safe for people with aggressive B cell lymphoma that has come back or not responded to prior treatments. Mosunetuzumab is an engineered antibody that helps the body's T cells recognize and k…

Matched conditions: TRANSFORMED LYMPHOMA

Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC

TRANSFORMED LYMPHOMA

Get alerted when new TRANSFORMED LYMPHOMA trials appear

Immune-Guiding antibody aims to clean up remaining cancer cells after transplant